Published in Psychiatr Clin North Am on September 01, 2007
Psychiatric comorbidities and schizophrenia. Schizophr Bull (2008) 2.69
Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review. Ther Adv Psychopharmacol (2013) 1.19
Decline in hospitalization risk and health care cost after initiation of depot antipsychotics in the treatment of schizophrenia. Clinicoecon Outcomes Res (2011) 1.16
Medication adherence in schizophrenia. World J Psychiatry (2012) 0.98
Cost-effectiveness of pharmacological and psychosocial interventions for schizophrenia. Cost Eff Resour Alloc (2011) 0.98
Risperidone long-acting injection: a review of its long term safety and efficacy. Neuropsychiatr Dis Treat (2008) 0.98
Beyond the usual suspects: positive attitudes towards positive symptoms is associated with medication noncompliance in psychosis. Schizophr Bull (2012) 0.91
A comparison of various methods of measuring antidepressant medication adherence among children and adolescents with major depressive disorder in a 12-week open trial of fluoxetine. J Child Adolesc Psychopharmacol (2010) 0.87
A retrospective observational study of the effectiveness of paliperidone palmitate on acute inpatient hospitalization rates. Int Clin Psychopharmacol (2015) 0.86
A comparison of adherence to hypoglycemic medications between Type 2 diabetes patients with and without serious mental illness. Psychiatry Res (2011) 0.85
Consumer empowerment and self-advocacy outcomes in a randomized study of peer-led education. Community Ment Health J (2012) 0.85
Cure or curse? Ambivalent attitudes towards neuroleptic medication in schizophrenia and non-schizophrenia patients. Ment Illn (2009) 0.83
What's in a name? Compliance, adherence and concordance in chronic psychiatric disorders. World J Psychiatry (2014) 0.81
Can we trust the internet to measure psychotic symptoms? Schizophr Res Treatment (2013) 0.79
The management of schizophrenia: focus on extended-release quetiapine fumarate. Neuropsychiatr Dis Treat (2011) 0.78
The Potential Role of Long-acting Injectable Antipsychotics in People with Schizophrenia and Comorbid Substance Use. J Dual Diagn (2012) 0.77
Beliefs about antipsychotic versus hypoglycemic medications among individuals with serious mental illness and type 2 diabetes. Patient Prefer Adherence (2012) 0.76
Long-acting injectable risperidone in partially adherent and nonadherent patients with schizophrenia. Neuropsychiatr Dis Treat (2011) 0.76
Optimal sampling of antipsychotic medicines: a pharmacometric approach for clinical practice. Br J Clin Pharmacol (2014) 0.76
The Promises and Challenges of Ecological Momentary Assessment in Schizophrenia: Development of an Initial Experimental Protocol. Healthcare (Basel) (2015) 0.76
Coverage of atypical antipsychotics among medicare drug plans in the state of washington: changes between 2007 and 2008. Prim Care Companion J Clin Psychiatry (2009) 0.76
Cognitive behavior therapy for people with schizophrenia. Psychiatry (Edgmont) (2009) 0.75
Analysis of patients attending a private psychiatric clinic. Indian J Psychiatry (2012) 0.75
Feasibility and acceptability of post-hospitalization ecological momentary assessment in patients with psychotic-spectrum disorders. Compr Psychiatry (2017) 0.75
The effect of providing patient-specific electronically monitored antipsychotic medication adherence results on the treatment planning of prescribers of outpatients with schizophrenia. Psychiatry Res (2013) 0.75
A review of behavioral tailoring strategies for improving medication adherence in serious mental illness. Dialogues Clin Neurosci (2016) 0.75
Patient perspectives in the development and use of long-acting antipsychotics in schizophrenia: focus on olanzapine long-acting injection. Patient Prefer Adherence (2009) 0.75
Sequential treatment with fluoxetine and relapse--prevention CBT to improve outcomes in pediatric depression. Am J Psychiatry (2014) 2.72
Analysis of risk factors for glans dehiscence after tubularized incised plate hypospadias repair. J Urol (2011) 2.22
Cognitive-behavioral therapy to prevent relapse in pediatric responders to pharmacotherapy for major depressive disorder. J Am Acad Child Adolesc Psychiatry (2008) 1.79
Brain activity in adolescent major depressive disorder before and after fluoxetine treatment. Am J Psychiatry (2012) 1.61
Prevalence and risk factors for renal scars in children with febrile UTI and/or VUR: a cross-sectional observational study of 565 consecutive patients. J Pediatr Urol (2013) 1.50
Acute myocardial infarction in young adults who abuse amphetamines. Drug Alcohol Depend (2008) 1.28
The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder. Schizophr Res (2008) 1.26
Variations of weight loss following gastric bypass and gastric band. Ann Surg (2008) 1.13
White matter hyperintensities: use of aortic arch pulse wave velocity to predict volume independent of other cardiovascular risk factors. Radiology (2013) 1.01
Prestorage leukoreduction ameliorates the effects of aging on banked blood. J Trauma (2010) 0.95
A randomized, double-blinded, placebo-controlled pilot trial of anticoagulation in low-risk traumatic brain injury: The Delayed Versus Early Enoxaparin Prophylaxis I (DEEP I) study. J Trauma Acute Care Surg (2012) 0.91
Symptom improvement and residual symptoms during acute antidepressant treatment in pediatric major depressive disorder. J Child Adolesc Psychopharmacol (2010) 0.90
Prestorage leukoreduction abrogates the detrimental effect of aging on packed red cells transfused after trauma: a prospective cohort study. Am J Surg (2011) 0.90
Insomnia moderates outcome of serotonin-selective reuptake inhibitor treatment in depressed youth. J Child Adolesc Psychopharmacol (2012) 0.89
Predictors of treatment response in adolescents with comorbid substance use disorder and attention-deficit/hyperactivity disorder. J Subst Abuse Treat (2012) 0.87
Attention training for school-aged children with ADHD: results of an open trial. J Atten Disord (2009) 0.87
Subjective quality of life and sexual dysfunction in outpatients with schizophrenia or schizoaffective disorder. J Sex Marital Ther (2013) 0.86
Functional connectivity of brain structures correlates with treatment outcome in major depressive disorder. Front Psychiatry (2011) 0.85
Sexual dysfunction associated with second-generation antipsychotics in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of olanzapine, risperidone, and quetiapine. Schizophr Res (2006) 0.85
Attention-deficit/hyperactivity disorder subtypes in adolescents with comorbid substance-use disorder. Am J Drug Alcohol Abuse (2011) 0.84
Preliminary data suggesting the efficacy of attention training for school-aged children with ADHD. Dev Cogn Neurosci (2012) 0.84
Increased cortical excitability with prefrontal high-frequency repetitive transcranial magnetic stimulation in adolescents with treatment-resistant major depressive disorder. J Child Adolesc Psychopharmacol (2012) 0.81
Aortic dissection in young adults who abuse amphetamines. Am Heart J (2010) 0.81
A randomized controlled trial comparing motivational interviewing in education to structured diabetes education in teens with type 1 diabetes. Diabetes Care (2010) 0.80
Evidence for increased glutamatergic cortical facilitation in children and adolescents with major depressive disorder. JAMA Psychiatry (2013) 0.79
An empirical evaluation of the Arizona sexual experience scale and a simple one-item screening test for assessing antipsychotic-related sexual dysfunction in outpatients with schizophrenia and schizoaffective disorder. Schizophr Res (2005) 0.79
Risk of methylphenidate-induced prehypertension in normotensive adult smokers with attention deficit hyperactivity disorder. J Clin Hypertens (Greenwich) (2012) 0.78
Heart Rate Recovery and Systolic Blood Pressure Recovery After Maximal Exercise in Prevalent Users of Stimulant Medications. J Clin Psychopharmacol (2016) 0.78
Metaparenting: associations with parenting stress, child-rearing practices, and retention in parents of children at risk for ADHD. Atten Defic Hyperact Disord (2011) 0.78
Outpatient diagnosis and clinical presentation of bipolar youth. J Can Acad Child Adolesc Psychiatry (2009) 0.77
Reliability and validity of the global assessment of relational functioning (GARF) in a psychiatric family therapy clinic. J Marital Fam Ther (2010) 0.76
Metacognitive executive function training for young children with ADHD: a proof-of-concept study. Atten Defic Hyperact Disord (2015) 0.76
Sexual functioning associated with quetiapine switch vs. risperidone continuation in outpatients with schizophrenia or schizoaffective disorder: a randomized double-blind pilot trial. Psychiatry Res (2008) 0.75
An open-label trial of quetiapine for antipsychotic-induced sexual dysfunction. J Sex Marital Ther (2005) 0.75
Urinary albumin to creatinine ratio as potential biomarker for cerebral microvascular disease. Curr Neurovasc Res (2014) 0.75
Creation of a decision aid for goal setting after geriatric burns: a study from the prognostic assessment of life and limitations after trauma in the elderly [PALLIATE] consortium. J Trauma Acute Care Surg (2016) 0.75
The Relationship Between Frailty and the Subjective Decision to Conduct a Goals of Care Discussion With Burned Elders. J Burn Care Res (2017) 0.75
A comparison of prognosis calculators for geriatric trauma: A P.A.L.LI.A.T.E. consortium study. J Trauma Acute Care Surg (2017) 0.75
Multicenter external validation of the Geriatric Trauma Outcome Score: A study by the Prognostic Assessment of Life and Limitations After Trauma in the Elderly (PALLIATE) consortium. J Trauma Acute Care Surg (2016) 0.75